$LIVN News

LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit

LivaNova to Present at Goldman Sachs Global Healthcare Conference in June

LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know

Why LivaNova (LIVN) Is Up 18.0% After Boosting 2026 Outlook And Winning Aura6000 FDA Approval

LivaNova (LIVN) Q1 2025 Earnings Transcript

Barclays Maintains Equal-Weight on LivaNova, Raises Price Target to $76

Mizuho Maintains Outperform on LivaNova, Raises Price Target to $90

Baird Maintains Outperform on LivaNova, Lowers Price Target to $76

LivaNova PLC Q1 2026 Earnings Call Summary

LivaNova Q1 Earnings Call Highlights

LivaNova (LIVN) Q2 2025 Earnings Transcript

LivaNova (LIVN) Q3 2025 Earnings Transcript

LivaNova (LIVN) Q1 2026 Earnings Transcript

LivaNova PLC (LIVN) Q1 2026 Earnings Call Transcript

LivaNova (LIVN) beats quarterly expectations but shares slip on cautious guidance reaction

LivaNova PLC (NASDAQ:LIVN) Beats Q1 Estimates, Lifts Full-Year Guidance

LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates

LivaNova Q1 2026 Earnings Call Transcript

LivaNova Raises FY2026 Sales Guidance from $1.431B-$1.445B to $1.445B-$1.458B vs $1.494B Est

LivaNova Raises FY2026 Adj EPS Guidance from $4.15-$4.25 to $4.20-$4.30 vs $4.21 Est;